Antimicrobial Resistance of Listeria monocytogenes from Animal Foods to First- and Second-Line Drugs in the Treatment of Listeriosis from 2008 to 2021: A Systematic Review and Meta-Analysis

First-line drugs for the treatment of listeriosis are the same around the world, but particular conditions might reduce their efficacy, including antimicrobial resistance. Therefore, this study aimed to verify, based on a systematic review and meta-analysis, whether the prevalence of antimicrobial r...

Full description

Saved in:
Bibliographic Details
Main Authors: Jaqueline Oliveira Dos Reis, Bruno Serpa Vieira, Adelino Cunha Neto, Vinicius Silva Castro, Eduardo Eustáquio de Souza Figueiredo
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2022/1351983
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552937619980288
author Jaqueline Oliveira Dos Reis
Bruno Serpa Vieira
Adelino Cunha Neto
Vinicius Silva Castro
Eduardo Eustáquio de Souza Figueiredo
author_facet Jaqueline Oliveira Dos Reis
Bruno Serpa Vieira
Adelino Cunha Neto
Vinicius Silva Castro
Eduardo Eustáquio de Souza Figueiredo
author_sort Jaqueline Oliveira Dos Reis
collection DOAJ
description First-line drugs for the treatment of listeriosis are the same around the world, but particular conditions might reduce their efficacy, including antimicrobial resistance. Therefore, this study aimed to verify, based on a systematic review and meta-analysis, whether the prevalence of antimicrobial resistance in Listeria monocytogenes from animal foods is higher for first- or second-line antimicrobials. From the total of 302 identified studies, 16 met all the eligibility criteria from 2008 to 2021 and were included in this meta-analysis. They comprised a dataset of 1152 L. monocytogenes isolates, obtained from different animal food products, food processing environment, and live animals. The included studies were developed in South America (n = 5), Europe (n = 4), Asia (n = 3), Africa (n = 2), and North America (n = 2), testing a total of 35 different antimicrobials, 11 of them classified as first-line drugs. Complete lack of antimicrobial resistance across the studies (all L. monocytogenes isolates tested as susceptible) was only observed for linezolid, while widespread antimicrobial resistance (all L. monocytogenes isolates tested resistant) was described for amoxicillin, benzylpenicillin, cefoxitin, fusidic acid, imipenem, sulfamethoxazole, and vancomycin. Overall, the meta-analysis results indicated no evidence that antimicrobial resistance in L. monocytogenes isolated from animal-based food is higher for first-line antimicrobials compared to second-line compounds (p=0.37). A greater volume of publication, together with better characterization of the isolates, is still needed for a more precise estimate of the real prevalence of antimicrobial resistance in L. monocytogenes.
format Article
id doaj-art-af74010eb42d48799e7c782e6effb7f9
institution Kabale University
issn 1918-1493
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-af74010eb42d48799e7c782e6effb7f92025-02-03T05:57:31ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932022-01-01202210.1155/2022/1351983Antimicrobial Resistance of Listeria monocytogenes from Animal Foods to First- and Second-Line Drugs in the Treatment of Listeriosis from 2008 to 2021: A Systematic Review and Meta-AnalysisJaqueline Oliveira Dos Reis0Bruno Serpa Vieira1Adelino Cunha Neto2Vinicius Silva Castro3Eduardo Eustáquio de Souza Figueiredo4Faculty of Agronomy and Animal ScienceFaculty of Animal ScienceFaculty of NutritionDepartment of Biological ScienceFaculty of Agronomy and Animal ScienceFirst-line drugs for the treatment of listeriosis are the same around the world, but particular conditions might reduce their efficacy, including antimicrobial resistance. Therefore, this study aimed to verify, based on a systematic review and meta-analysis, whether the prevalence of antimicrobial resistance in Listeria monocytogenes from animal foods is higher for first- or second-line antimicrobials. From the total of 302 identified studies, 16 met all the eligibility criteria from 2008 to 2021 and were included in this meta-analysis. They comprised a dataset of 1152 L. monocytogenes isolates, obtained from different animal food products, food processing environment, and live animals. The included studies were developed in South America (n = 5), Europe (n = 4), Asia (n = 3), Africa (n = 2), and North America (n = 2), testing a total of 35 different antimicrobials, 11 of them classified as first-line drugs. Complete lack of antimicrobial resistance across the studies (all L. monocytogenes isolates tested as susceptible) was only observed for linezolid, while widespread antimicrobial resistance (all L. monocytogenes isolates tested resistant) was described for amoxicillin, benzylpenicillin, cefoxitin, fusidic acid, imipenem, sulfamethoxazole, and vancomycin. Overall, the meta-analysis results indicated no evidence that antimicrobial resistance in L. monocytogenes isolated from animal-based food is higher for first-line antimicrobials compared to second-line compounds (p=0.37). A greater volume of publication, together with better characterization of the isolates, is still needed for a more precise estimate of the real prevalence of antimicrobial resistance in L. monocytogenes.http://dx.doi.org/10.1155/2022/1351983
spellingShingle Jaqueline Oliveira Dos Reis
Bruno Serpa Vieira
Adelino Cunha Neto
Vinicius Silva Castro
Eduardo Eustáquio de Souza Figueiredo
Antimicrobial Resistance of Listeria monocytogenes from Animal Foods to First- and Second-Line Drugs in the Treatment of Listeriosis from 2008 to 2021: A Systematic Review and Meta-Analysis
Canadian Journal of Infectious Diseases and Medical Microbiology
title Antimicrobial Resistance of Listeria monocytogenes from Animal Foods to First- and Second-Line Drugs in the Treatment of Listeriosis from 2008 to 2021: A Systematic Review and Meta-Analysis
title_full Antimicrobial Resistance of Listeria monocytogenes from Animal Foods to First- and Second-Line Drugs in the Treatment of Listeriosis from 2008 to 2021: A Systematic Review and Meta-Analysis
title_fullStr Antimicrobial Resistance of Listeria monocytogenes from Animal Foods to First- and Second-Line Drugs in the Treatment of Listeriosis from 2008 to 2021: A Systematic Review and Meta-Analysis
title_full_unstemmed Antimicrobial Resistance of Listeria monocytogenes from Animal Foods to First- and Second-Line Drugs in the Treatment of Listeriosis from 2008 to 2021: A Systematic Review and Meta-Analysis
title_short Antimicrobial Resistance of Listeria monocytogenes from Animal Foods to First- and Second-Line Drugs in the Treatment of Listeriosis from 2008 to 2021: A Systematic Review and Meta-Analysis
title_sort antimicrobial resistance of listeria monocytogenes from animal foods to first and second line drugs in the treatment of listeriosis from 2008 to 2021 a systematic review and meta analysis
url http://dx.doi.org/10.1155/2022/1351983
work_keys_str_mv AT jaquelineoliveiradosreis antimicrobialresistanceoflisteriamonocytogenesfromanimalfoodstofirstandsecondlinedrugsinthetreatmentoflisteriosisfrom2008to2021asystematicreviewandmetaanalysis
AT brunoserpavieira antimicrobialresistanceoflisteriamonocytogenesfromanimalfoodstofirstandsecondlinedrugsinthetreatmentoflisteriosisfrom2008to2021asystematicreviewandmetaanalysis
AT adelinocunhaneto antimicrobialresistanceoflisteriamonocytogenesfromanimalfoodstofirstandsecondlinedrugsinthetreatmentoflisteriosisfrom2008to2021asystematicreviewandmetaanalysis
AT viniciussilvacastro antimicrobialresistanceoflisteriamonocytogenesfromanimalfoodstofirstandsecondlinedrugsinthetreatmentoflisteriosisfrom2008to2021asystematicreviewandmetaanalysis
AT eduardoeustaquiodesouzafigueiredo antimicrobialresistanceoflisteriamonocytogenesfromanimalfoodstofirstandsecondlinedrugsinthetreatmentoflisteriosisfrom2008to2021asystematicreviewandmetaanalysis